Tenofovir or Entecavir Monotherapy improves survival compared to Lamivudine in patients with Decompensated Liver Disease due to Chronic Hepatitis B

被引：0
|
作者：
Manolakopoulos, Spilios [1 ]
Deutsch, Melanie [1 ]
Triantos, Christos K. [2 ]
Mathou, Nikoletta [3 ]
Mela, Maria [4 ]
Striki, Athanasia [1 ]
Kalafateli, Maria [2 ]
Kontos, Georgios [1 ]
Kranidioti, Hariklia [1 ]
Manesis, Emanuel K. [5 ]
Papatheodoridis, George V. [1 ]
机构：
[1] Hippokrateion Hosp, Acad Dept Internal Med 2, Athens, Greece
[2] Univ Patras, Dept Gastroenterol, Patras, Greece
[3] Konstantopoulio Gen Hosp Athens, Dept Gastroenterol, Athens, Greece
[4] Polyclin Gen Hosp Athens, Dept Gastroenterol, Athens, Greece
[5] Univ Athens, Sch Med, Dept Internal Med, GR-11527 Athens, Greece
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
944
引用
收藏
页码：660A / 660A
页数：1
相关论文
共 50 条
  • [1] Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver Disease
    Liaw, Yun-Fan
    Sheen, I-Shyan
    Lee, Chuan-Mo
    Akarca, Ulus Salih
    Papatheodoridis, George V.
    Wong, Florence Suet-Hing
    Chang, Ting-Tsung
    Horban, Andrzej
    Wang, Chia
    Kwan, Peter
    Buti, Maria
    Prieto, Martin
    Berg, Thomas
    Kitrinos, Kathryn
    Peschell, Ken
    Mondou, Elsa
    Frederick, David
    Rousseau, Franck
    Schiff, Eugene R.
    HEPATOLOGY, 2011, 53 (01) : 62 - 72
  • [2] Chronic Hepatitis B: Tenofovir and Entecavir compared
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (09):
  • [3] Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance
    Lee, S.
    Ahn, S. H.
    Jung, K. S.
    Kim, D. Y.
    Kim, B. K.
    Kim, S. U.
    Baatarkhuu, O.
    Ku, H. J.
    Han, K.
    Park, J. Y.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (02) : 141 - 147
  • [4] Comparable efficacy with entecavir monotherapy and tenofovir-entecavir combination in chronic hepatitis B patients
    Baqai, Sumbella
    Proudfoot, James
    Xu, Ronghui
    Kane, Steve
    Clark, Margaret
    Gish, Robert
    BMJ OPEN GASTROENTEROLOGY, 2015, 2 (01):
  • [5] Entecavir monotherapy for lamivudine-refractory chronic hepatitis B
    Goulis, Ioannis
    Dalekos, George N.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (06) : 855 - 859
  • [6] Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
    Park, Chan Ho
    Jung, Seok Won
    Shin, Jung Woo
    Bae, Mi Ae
    Lee, Yoon Im
    Park, Yong Tae
    Chung, Hwa Sik
    Park, Neung Hwa
    CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (01) : 152 - 159
  • [7] EFFICACY OF COMBINATION OF ENTECAVIR AND TENOFOVIR TREATMENT IN HEPATITIS B RELATED DECOMPENSATED CHRONIC LIVER DISEASE: PILOT STUDY
    Amarapurkar, D.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S327 - S327
  • [8] Lamivudine treatment of advanced and decompensated liver disease due to hepatitis B
    VanThiel, DH
    Friedlander, L
    Kania, RJ
    Molloy, PJ
    Hassanein, T
    Wahlstrom, E
    Faruki, H
    HEPATO-GASTROENTEROLOGY, 1997, 44 (15) : 808 - 812
  • [9] TENOFOVIR VERSUS TENOFOVIR PLUS ENTECAVIR FOR CHRONIC HEPATITIS B WITH LAMIVUDINE-RESISTANCE AND ENTECAVIR-RESISTANCE
    Lee, S.
    Ahn, S. H.
    Jung, K. S.
    Kim, D. Y.
    Kim, B. K.
    Kim, S. U.
    Baatarkhuu, O.
    Ku, H. J.
    Han, K-H
    Park, J. Y.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S595 - S595
  • [10] Efficacy of lamivudine therapy on decompensated liver cirrhosis due to chronic hepatitis B
    Yousefi-Mashhour, Mahmood
    Mansour-Ghanaei, Fariborz
    Foroutan, Hosein
    Ghofrani, Hadi
    Purrasuli, Zahra
    Joukar, Farahnaz
    HEPATITIS MONTHLY, 2007, 7 (02) : 77 - 81
12345